May 2006
Volume 47, Issue 13
ARVO Annual Meeting Abstract  |   May 2006
Intraocular Inflammation After Heart Transplantation
Author Affiliations & Notes
  • C.M. Deuter
    Ophthalmology I, University of Tuebingen, Tuebingen, Germany
  • J.M. Rohrbach
    Ophthalmology I, University of Tuebingen, Tuebingen, Germany
  • D. Doycheva
    Ophthalmology I, University of Tuebingen, Tuebingen, Germany
  • M. Zierhut
    Ophthalmology I, University of Tuebingen, Tuebingen, Germany
  • Footnotes
    Commercial Relationships  C.M. Deuter, None; J.M. Rohrbach, None; D. Doycheva, None; M. Zierhut, None.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 2418. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C.M. Deuter, J.M. Rohrbach, D. Doycheva, M. Zierhut; Intraocular Inflammation After Heart Transplantation . Invest. Ophthalmol. Vis. Sci. 2006;47(13):2418.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : After solid organ transplantation with immunosuppressive treatment rarely intraocular inflammation has been described. In case of a posttransplantation lymphoproliferative disorder (PTLD), Epstein–Barr virus (EBV) seems to play a major role.

Methods: : We present 3 patients with uveitis after heart transplantation.

Results: : Three patients (2 male, 1 female, age 7, 8 and 44 years) were diagnosed with anterior uveitis with iris nodules (the two young boys) or intermediate uveitis. All three patients had a heart–transplantation and were on a double immunosuppression. While in the first two cases EBV–load was found massively elevated (in one patient EBV was also stainable in an iris biopsy), diagnostic vitrectomy (ppV) in the third patient was not able to demonstrate a viral, bacterial or lymphoma origin, but disclosed a polyclonal lymphocytic proliferation. Also the EBV–viral load was not elevated. The therapy of the first 2 young children consisted of ex vivo generated anti–EBV–cytotoxic T–cells. This led to complete response of the iris nodules in both, but to a reduction of the EBV–load only in one child. In the third patient postoperative improvement was achieved without additional treatment.

Conclusions: : The posttransplantation lymphoproliferative disorder (PTLD) is a rare entity, but probably with growing incidence. A few cases of uveitis have been described; rarely EBV has been detected in the eye. It seems very important to analyse the role of EBV in this disorder, because the immunotherapy with anti–EBV–cytotoxic T–cells was effective in the treatment of the uveitis, in one patient also leading to a massive reduction of the EBV–load. The etiology of the uveitis in patient number three remains unclear.

Keywords: uvea • inflammation • tumors 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.